See more : CTR Investments & Consulting, Inc. (CIVX) Income Statement Analysis – Financial Results
Complete financial analysis of China Health Group Inc. (8225.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Health Group Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Aperam S.A. (APEMY) Income Statement Analysis – Financial Results
- Vitalhub Corp. (VHI.TO) Income Statement Analysis – Financial Results
- Gawk Incorporated (GAWK) Income Statement Analysis – Financial Results
- FiscalNote Holdings, Inc. (NOTE) Income Statement Analysis – Financial Results
- Lee Pharmaceuticals, Inc. (LPHM) Income Statement Analysis – Financial Results
China Health Group Inc. (8225.HK)
About China Health Group Inc.
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.43M | 13.09M | 83.60M | 83.06M | 63.22M | 59.61M | 58.49M | 20.24M | 20.50M | 5.96M | 14.93M | 28.69M | 18.10M | 37.69M | 47.31M | 39.19M | 38.73M | 57.05M | 42.16M | 36.16M | 35.68M | 32.45M |
| Cost of Revenue | 13.21M | 7.35M | 19.74M | 16.10M | 9.75M | 7.24M | 2.08M | 3.36M | 4.98M | 3.06M | 20.11M | 16.24M | 11.09M | 16.32M | 20.67M | 23.80M | 15.77M | 24.77M | 20.12M | 17.39M | 7.21M | 9.38M |
| Gross Profit | 8.21M | 5.74M | 63.86M | 66.96M | 53.47M | 52.37M | 56.42M | 16.88M | 15.52M | 2.90M | -5.18M | 12.45M | 7.01M | 21.37M | 26.63M | 15.38M | 22.96M | 32.29M | 22.04M | 18.77M | 28.47M | 23.08M |
| Gross Profit Ratio | 38.33% | 43.87% | 76.38% | 80.61% | 84.58% | 87.85% | 96.45% | 83.41% | 75.70% | 48.71% | -34.70% | 43.40% | 38.70% | 56.70% | 56.30% | 39.25% | 59.28% | 56.59% | 52.27% | 51.90% | 79.79% | 71.11% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.61M | 13.97M | 14.43M | 3.60M | 6.10M | 8.53M | 5.19M | 4.39M | 5.38M | 12.74M | 20.90M | 17.45M | 51.31M | 62.59M | 17.30M | 47.54M | 18.17M | 17.54M | 16.59M | 11.87M | 9.57M | 3.62M |
| Selling & Marketing | 57.94M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 65.54M | 13.97M | 14.43M | 3.60M | 6.10M | 8.53M | 5.19M | 4.39M | 5.38M | 12.74M | 20.90M | 17.45M | 51.31M | 62.59M | 17.30M | 47.54M | 18.17M | 17.54M | 16.59M | 11.87M | 9.57M | 3.62M |
| Other Expenses | 0.00 | 7.83M | 7.34M | 8.29M | 14.75M | 16.15M | 0.00 | 0.00 | -2.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 191.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 66.54M | 21.80M | 21.77M | 11.89M | 20.85M | 24.68M | 22.45M | 14.01M | 12.19M | 41.37M | 21.56M | 13.78M | 49.94M | 40.37M | 15.24M | 35.23M | 15.73M | 17.54M | 16.59M | 7.29M | 6.48M | 3.53M |
| Cost & Expenses | 79.75M | 29.15M | 41.51M | 27.99M | 30.60M | 31.92M | 24.53M | 17.37M | 17.17M | 44.42M | 41.67M | 30.02M | 61.04M | 56.68M | 35.91M | 59.03M | 31.50M | 42.31M | 36.71M | 24.68M | 13.69M | 12.90M |
| Interest Income | 116.00K | 202.00K | 430.00K | 234.00K | 9.00K | 45.00K | 8.00K | 9.00K | 7.00K | 151.00K | 4.22M | 22.00K | 298.00K | 265.00K | 1.08M | 573.00K | 1.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 17.00K | 15.00K | 163.00K | 172.00K | 63.00K | 76.00K | 800.00K | 817.00K | 0.00 | 0.00 | 3.77M | 4.94M | 960.00K | 6.30M | 7.97M | 5.34M | 1.55M | 172.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 234.00K | 151.00K | 201.00K | 291.00K | 1.27M | 1.04M | 1.02M | 1.03M | 1.21M | 1.15M | 1.79M | 2.71M | 2.58M | 5.94M | 2.91M | 4.07M | 2.92M | 1.32M | 1.46M | 463.00K | 194.00K | 314.00K |
| EBITDA | -57.98M | -15.66M | 42.74M | 55.67M | 33.90M | 28.73M | 34.99M | 3.91M | 1.81M | -7.50M | -24.29M | 9.71M | -142.25M | -48.52M | 15.52M | -15.20M | 10.14M | 21.70M | 7.29M | 11.94M | 22.19M | 19.86M |
| EBITDA Ratio | -270.60% | -119.62% | 51.10% | 67.02% | 53.62% | 48.28% | 59.83% | 19.35% | 8.85% | -125.86% | -162.69% | 0.16% | -182.94% | -69.86% | 32.80% | -38.80% | 26.19% | 37.94% | 16.40% | 33.03% | 62.19% | 61.21% |
| Operating Income | -57.33M | -15.81M | 42.52M | 55.37M | 32.63M | 27.73M | 33.97M | 2.89M | 172.00K | -8.65M | -26.08M | -7.94M | -100.26M | -40.86M | 11.53M | -19.85M | 7.23M | 20.38M | 5.45M | 11.48M | 21.99M | 19.55M |
| Operating Income Ratio | -267.57% | -120.77% | 50.86% | 66.67% | 51.61% | 46.52% | 58.08% | 14.25% | 0.84% | -145.23% | -174.68% | -27.67% | -553.93% | -108.42% | 24.37% | -50.65% | 18.66% | 35.71% | 12.93% | 31.75% | 61.64% | 60.24% |
| Total Other Income/Expenses | -884.00K | 185.00K | 3.00K | 15.42M | -172.00K | -63.00K | -68.00K | -800.00K | -3.17M | 52.77M | -4.89M | 11.17M | -49.52M | -14.56M | -5.22M | -7.40M | -3.81M | -1.60M | -360.00K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -58.21M | -15.83M | 42.52M | 70.80M | 32.45M | 27.67M | 33.90M | 2.09M | -3.38M | 44.12M | -30.97M | 3.23M | -149.77M | -55.42M | 6.31M | -27.24M | 1.89M | 18.77M | 6.40M | 11.48M | 21.99M | 19.55M |
| Income Before Tax Ratio | -271.70% | -120.90% | 50.86% | 85.23% | 51.34% | 46.42% | 57.95% | 10.30% | -16.47% | 740.72% | -207.39% | 11.26% | -827.52% | -147.06% | 13.34% | -69.52% | 4.87% | 32.91% | 15.19% | 31.75% | 61.64% | 60.24% |
| Income Tax Expense | 0.00 | 17.00K | 6.20M | 10.15M | 4.66M | 4.50M | 3.44M | -42.00K | 111.00K | 32.00K | 53.00K | 113.00K | 4.02M | 1.84M | 277.00K | -9.93M | 788.00K | 3.18M | 887.00K | 881.00K | 1.51M | 237.00K |
| Net Income | -58.01M | -15.84M | 36.33M | 60.65M | 27.79M | 23.16M | 30.45M | 2.13M | -3.35M | 44.12M | -31.03M | 3.12M | -153.80M | -56.93M | 6.28M | -16.35M | 1.60M | 15.56M | 5.64M | 10.77M | 20.23M | 18.94M |
| Net Income Ratio | -270.78% | -121.03% | 43.45% | 73.02% | 43.96% | 38.86% | 52.07% | 10.51% | -16.36% | 740.72% | -207.81% | 10.87% | -849.75% | -151.05% | 13.27% | -41.73% | 4.12% | 27.28% | 13.39% | 29.78% | 56.70% | 58.36% |
| EPS | -0.06 | -0.02 | 0.04 | 0.06 | 0.03 | 0.02 | 0.03 | 0.00 | 0.00 | 0.10 | -0.09 | 0.01 | -0.28 | -0.10 | 0.01 | -0.02 | 0.00 | 0.03 | 0.01 | 0.02 | 0.04 | 0.05 |
| EPS Diluted | -0.06 | -0.02 | 0.04 | 0.06 | 0.03 | 0.02 | 0.03 | 0.00 | 0.00 | 0.10 | -0.09 | 0.01 | -0.28 | -0.10 | 0.01 | -0.02 | 0.00 | 0.03 | 0.01 | 0.02 | 0.04 | 0.05 |
| Weighted Avg Shares Out | 995.35M | 995.35M | 995.35M | 994.06M | 992.77M | 992.77M | 992.77M | 915.48M | 906.46M | 458.51M | 364.67M | 544.51M | 544.37M | 543.32M | 542.27M | 659.74M | 538.07M | 538.07M | 538.07M | 538.07M | 468.05M | 403.55M |
| Weighted Avg Shares Out (Dil) | 995.35M | 995.35M | 995.35M | 997.11M | 992.77M | 992.77M | 992.77M | 915.48M | 915.27M | 458.65M | 364.67M | 544.51M | 544.37M | 543.32M | 542.27M | 659.74M | 570.06M | 538.07M | 562.38M | 538.07M | 470.45M | 403.55M |
Source: https://incomestatements.info
Category: Stock Reports